Collegium Pharmaceutical, Inc (COLL): Total Assets
$1.66B
As of 2025-12-31
$2.14B
As of 2026-06-30
+12.2%
3-year compound annual growth
+20.8%
5-year compound annual growth
+32.7%
10-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.66B | -0.4% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $1.66B | +45.5% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $1.14B | -2.6% | 2025-02-27, Balance as of period end |
| 2022-12-31 | $1.17B | +69.7% | 2024-02-22, Balance as of period end |
| 2021-12-31 | $692.08M | +7.5% | 2023-02-23, Balance as of period end |
| 2020-12-31 | $643.84M | +110.2% | 2022-02-24, Balance as of period end |
| 2019-12-31 | $306.30M | +5.2% | 2021-02-25, Balance as of period end |
| 2018-12-31 | $291.25M | +114.8% | 2020-02-27, Balance as of period end |
| 2017-12-31 | $135.57M | -16.3% | 2019-02-27, Balance as of period end |
| 2016-12-31 | $162.02M | +65.8% | 2018-03-07, Balance as of period end |
| 2015-12-31 | $97.72M | n/m | 2017-03-10, Balance as of period end |
| 2014-12-31 | $5.09M | n/a | 2016-03-18, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $1.66B | -0.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $836.65M | -0.5% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $1.32B | -5.1% |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 2025-09-30 | $1.39B | +21.5% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $1.26B | -18.6% |
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $1.63B | +3.3% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $1.45B | +6.2% |
| Harmony Biosciences Holdings, Inc. (HRMY) | 2025-12-31 | $1.27B | +27.3% |
| ANI Pharmaceuticals Inc (ANIP) | 2025-12-31 | $1.44B | +12.1% |
Compare COLL, CORT, EBS, ARWR side by side · Screen every company in Pharmaceutical Preparations ↗